MedTrace Logo

A COVID-19 Symptom, Exposure and Immune Response Registry

NCT04348942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 804

Last updated 2022-03-04

No results posted yet for this study

Summary

This is a 6-month, 100% remote study that will collect a broad range of data that may provide insight into the COVID-19 global pandemic. Data collected will include participant medical histories, history of prior SARS-CoV-2 infection and exposure to known cases. On an ongoing basis data will be collected on new contacts with known cases, the presence of COVID-19 symptoms, including severity and outcome, and information on the immune system response to SARS-CoV-2 infection.

Conditions

Sponsors & Collaborators

  • ObvioHealth

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2021-03-21
Completion
2021-03-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04348942 on ClinicalTrials.gov